You are here: Industry Insights > Market News > Parexel launches Health Advances Asia, expanding global footprint with Hong Kong, S.A.R., China base

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Parexel launches Health Advances Asia, expanding global footprint with Hong Kong, S.A.R., China base

fiercepharmaJuly 28, 2019

Tag: PAREXEL , Health Advances Asia , global footprint

Favorites

The so-called Health Advances Asia Limited subsidiary, which forms part of Parexel's consulting unit, is set up to "support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong, S.A.R., China presence," according to the firm.

It will be led by biopharma and medtech veteran Gary Cheng, who will be in charge of the local team. Cheng, who counts Novartis, BD, Chiron, Alere and Aventis among his former employers, will also work with Vivek Mittal, a long-time partner at Health Advances in its San Francisco office who will now be based in Hong Kong, S.A.R., China Special Administrative Region in China.

Previous:Key European committee backs GW's Epidyolex, Bayer's Vitrakvi and more

Next:GOP senators distance themselves from Grassley, Trump's efforts to cut drug prices

Parexel launches Health Advances Asia, expanding global footprint with Hong Kong, S.A.R., China base

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

Parexel launches Health Advances Asia, expanding global footprint with Hong Kong, S.A.R., China base

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>